Emerging Therapies in the Management of High-Grade Serous Ovarian Carcinoma: a Focus on PARP Inhibitors
Crossref DOI link: https://doi.org/10.1007/s13669-017-0215-1
Published Online: 2017-07-22
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Machado, Karime Kalil
Gaillard, Stéphanie L.
License valid from 2017-07-22